Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis

Haruka Koizumi; Atsushi Tokuriki; Noritaka Oyama; Hideki Ido; Kazumitsu Sugiura; Masashi Akiyama; Minoru Hasegawa

doi:10.1111/1346-8138.13530

Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis

Haruka Koizumi, Atsushi Tokuriki, Noritaka Oyama, Hideki Ido, Kazumitsu Sugiura, Masashi Akiyama, Minoru Hasegawa

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	723-724
Number of pages	2
Journal	Journal of Dermatology
Volume	44
Issue number	6
DOIs	https://doi.org/10.1111/1346-8138.13530
Publication status	Published - 06-2017
Externally published	Yes

All Science Journal Classification (ASJC) codes

Dermatology

Access to Document

10.1111/1346-8138.13530

Cite this

Koizumi, Haruka ; Tokuriki, Atsushi ; Oyama, Noritaka ; Ido, Hideki ; Sugiura, Kazumitsu ; Akiyama, Masashi ; Hasegawa, Minoru. / Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis. In: Journal of Dermatology. 2017 ; Vol. 44, No. 6. pp. 723-724.

@article{a7caa46063de46359a04973b6c1d21cf,

title = "Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis",

author = "Haruka Koizumi and Atsushi Tokuriki and Noritaka Oyama and Hideki Ido and Kazumitsu Sugiura and Masashi Akiyama and Minoru Hasegawa",

year = "2017",

month = jun,

doi = "10.1111/1346-8138.13530",

language = "English",

volume = "44",

pages = "723--724",

journal = "Journal of Dermatology",

issn = "0385-2407",

publisher = "Wiley-Blackwell",

number = "6",

}

Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis. / Koizumi, Haruka; Tokuriki, Atsushi; Oyama, Noritaka; Ido, Hideki; Sugiura, Kazumitsu; Akiyama, Masashi; Hasegawa, Minoru.

In: Journal of Dermatology, Vol. 44, No. 6, 06.2017, p. 723-724.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis

AU - Koizumi, Haruka

AU - Tokuriki, Atsushi

AU - Oyama, Noritaka

AU - Ido, Hideki

AU - Sugiura, Kazumitsu

AU - Akiyama, Masashi

AU - Hasegawa, Minoru

PY - 2017/6

Y1 - 2017/6

UR - http://www.scopus.com/inward/record.url?scp=84986275141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84986275141&partnerID=8YFLogxK

U2 - 10.1111/1346-8138.13530

DO - 10.1111/1346-8138.13530

M3 - Letter

C2 - 27599405

AN - SCOPUS:84986275141

VL - 44

SP - 723

EP - 724

JO - Journal of Dermatology

JF - Journal of Dermatology

SN - 0385-2407

IS - 6

ER -

Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this